Large-scale testing (Phase 3)Study completedNCT00927914
What this trial is testing
Evaluating the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimotor Polyneuropathy
Who this might be right for
Mild to Moderate Diabetic Sensorimotor Polyneuropathy
Eisai Inc. 800